Search

Your search keyword '"González-Neira, Anna"' showing total 710 results

Search Constraints

Start Over You searched for: Author "González-Neira, Anna" Remove constraint Author: "González-Neira, Anna"
710 results on '"González-Neira, Anna"'

Search Results

1. Understanding the genetic complexity of puberty timing across the allele frequency spectrum.

2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.

3. Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival

4. Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum

5. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

6. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

7. Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

8. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

9. Rare germline copy number variants (CNVs) and breast cancer risk

10. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

12. FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women

14. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

15. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

16. Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review

17. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.

18. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

19. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

20. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

21. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

22. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

23. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

24. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

25. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

26. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium

27. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

28. Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

29. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.

30. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

31. Genome-wide association study of germline variants and breast cancer-specific mortality.

32. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

34. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

35. The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

36. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

37. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

38. Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis

39. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

40. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

41. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).

42. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

43. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

44. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

45. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

46. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

47. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.

48. RAD51B in Familial Breast Cancer.

49. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair.

50. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

Catalog

Books, media, physical & digital resources